StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Analyst target changes matter most when the new target creates a material gap versus current price or confirms a recent catalyst.
What happened, with direct paths to the underlying reporting
LB Pharmaceuticals target raised to 54 from 46; posted price 45.33; priceChangeSinceSignal 0.11
Target: $54
Posted price: $45.33
Analyst firm: BMO Capital
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.